Dare Bioscience Files 8-K Report
Ticker: DARE · Form: 8-K · Filed: Jul 25, 2025 · CIK: 1401914
| Field | Detail |
|---|---|
| Company | Dare Bioscience, INC. (DARE) |
| Form Type | 8-K |
| Filed Date | Jul 25, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, 8-k
TL;DR
Dare Bioscience filed an 8-K on 7/25/25 for 'Other Events' - check the full filing for details.
AI Summary
On July 25, 2025, Dare Bioscience, Inc. filed an 8-K report. The filing indicates "Other Events" as the primary item of disclosure. No specific financial transactions or material events were detailed in the provided excerpt.
Why It Matters
This filing signals that Dare Bioscience has made a disclosure to the SEC regarding an event. Investors should review the full filing for details on the nature of this event.
Risk Assessment
Risk Level: low — The provided excerpt is a standard SEC filing notification and does not contain specific material information that would inherently increase risk.
Key Players & Entities
- Dare Bioscience, Inc. (company) — Registrant
- July 25, 2025 (date) — Filing Date
- Delaware (jurisdiction) — State of Incorporation
- San Diego, CA (location) — Principal Executive Offices
- Cerulean Pharma Inc. (company) — Former Company Name
- Tempo Pharmaceuticals Inc (company) — Former Company Name
FAQ
What is the exact date of the earliest event reported in this 8-K filing?
The date of the earliest event reported is July 25, 2025.
What is the primary item of disclosure for this 8-K filing?
The primary item of disclosure is 'Other Events'.
In which state is Dare Bioscience, Inc. incorporated?
Dare Bioscience, Inc. is incorporated in Delaware.
What is the principal executive office address of Dare Bioscience, Inc.?
The principal executive office address is 3655 Nobel Drive, Suite 260, San Diego, CA 92122.
What were some of Dare Bioscience's former company names?
Dare Bioscience was formerly known as Cerulean Pharma Inc. and Tempo Pharmaceuticals Inc.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on July 25, 2025 regarding Dare Bioscience, Inc. (DARE).